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The yeast Saccharomyces cerevisiae along with the bacterium Escherichia coli have been 
popular model organisms for the creation or modification of chemical producing or chemical 
sensing strains. Yeast has been used to express G-protein coupled receptors (GPCRs), seven-
transmembrane cell-surface receptors found in eukaryotes responsible for the detection toxins, 
pheromones, drugs, nutrients, and light. GPCRs have been used in the development of 
biosensors in yeast through the use of the signaling cascades, such as the endogenous yeast 
mating pathway and the heterologous cyclic adenosine monophosphate (cAMP) cascades. Use 
of two cascades simultaneously would allow for the creation of complex logic gates in yeast. 
Development of logic gates in yeast would allow for the detection of multiple chemicals by a single 
yeast cell. Here I present work toward the development of logic gates in yeast through the use of 
an engineered yeast mating pathway and a heterologous mammalian cAMP cascade. 
Chapter 1 provides an overview of previous work that sets the stage to the development 
of GPCR-based logic gates. Chapter 2 outlines the methods used to generate the strains and 
plasmids used in this study, and the methods used to collect and analyze the data. Chapter 3 
presents the initial results, demonstrating the use of the yeast mating pathway and the cAMP 
signaling cascade independently. Chapter 4 summarizes the conclusions that can be drawn, and 
provides a path to the establishment of GPCR-based logic gates.   
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CHAPTER 1: INTRODUCTION 
1.1 Biological Logic Gates 
The interconnectivity of regulatory elements in cells, be they ribonucleic acids (RNA)-, 
small molecule-, or protein-based, resembles that of electronic circuits1, 2. Living cells require 
highly dynamic signaling systems to monitor and execute appropriate physiological responses to 
varying internal and external states3. The dissection of these regulatory systems has in several 
cases been simplified to ignore the biochemical interactions between signaling molecules in favor 
of simplified logic-based models in order to examine the system in its entirety4, 5. The field of 
systems biology has tended to use these logical models in order to provide a more complete 
understanding of the system in question5-7 and provide a foundation to analyze individual 
components8. There is an increasing interest to use logical models to design synthetic signaling 
circuits3, 9, 10. Synthetic circuits have been of interest as a means to investigate and modify existing 
pathways11, 12, as well as to create new ones13, 14. Notable examples include RNA-based 
translational regulators such as aptamers15, 16 and antisense RNA17, the protein-based 
tetracycline repressor protein (TetR)18, and CRISPR/Cas9 based regulators19.  
1.2 Biosensors 
In addition to investigating and building regulatory pathways, synthetic signaling circuits 
have been adapted to make biosensors. Simple, single-input sensors have been shown to be an 
excellent means to detect chemicals20. Biosensors can detect chemicals through the production 
of a fluorescent signal. Previously generated biosensors detect chemicals such as the drug 
theophylline and the antimicrobial eugenol using green fluorescent protein (GFP) as a reporter15, 
16, 21, and the retinoid-like compound LG335, which was detected by adenine production22. More 
advanced biosensors use multiple inputs to produce more advanced responses. Multi-input 
sensors are required for cells to recognize and respond to the complex extracellular conditions 
they are subjected to, including pH, temperature, and osmotic pressure23, 24. Several multi-input 
systems have been generated that function in a manner resembling Boolean digital logic gates 
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seen in computers, including transcription factor based chemical sensors in E. coli23, 25, 26, light-
based edge detectors24, and mammalian transcriptional systems25. The development of cellular 
logic gates and customized signaling cascades have the potential to act as important tools for 
cell-based therapeutics27. This method has been proposed for induced pluripotent stem cells, 
where logic gates would allow for the reprograming of chromatin and generation of specific cell 
types. In addition, biosensors have the potential to guide evolution for the development of drug 
and biofuel producing microbes, allowing for the rapid screening and selection of highly producing 
strains28. While there has been extensive work in the area of intracellular sensors20, there has 
been less work using cell-surface receptors as a sensing unit29. The use of cell-surface receptors 
has the potential to expand the number of multi-input systems by detecting chemicals regardless 
of cell permeability. 
1.3 Cell Surface Receptors 
Cell surface receptors have the unique advantage over intracellular receptors of being 
able to detect chemicals that cannot penetrate the cell surface. Among them are receptor histidine 
kinases (RHK), receptor tyrosine kinases (RTKs), and GPCRs. Receptor histidine kinases are 
two component signaling systems, and are among the most widely used in nature30, and have 
been used previously to make light-based biosensors24. RHKs are abundant amongst prokaryotes 
to detect osmotic conditions, nutrients, and light30, 31, and are used for hormone detection in 
several eukaryotes32, such as with the fruiting hormone ethylene in plants33. No RHKs have been 
found in the animal kingdom30. RTKs are also two-component signaling systems that are primarily 
hormone detectors found in eukaryotes, detecting hormones, such as epidermal growth factor 
(EGF), vascular endothelial growth factor (VEGF), and insulin1, 34, 35. GPCRs are seven-
transmembrane domain receptors found in eukaryotes, where they are used to detect toxins, 
pheromones, drugs, nutrients, and even photons36, 37. GPCRs are highly relevant in the medical 
field as drug targets38. GPCRs are particularly appealing as a sensing unit due to the wide variety 




 Here I hypothesize that orthogonal GPCR-based sensors can be used to make logic 
gates by leveraging two different parallel signal processing units, i.e. the yeast mating pathway 
and the cAMP cascade, and connecting each of these cascades to a different heterologous GPCR 
for the sensing of two inputs independently (Fig. 1). The independence of each signal processing 
unit would allow for the generation of more complex signaling outputs. The advantage of using 
GPCRs as the sensor unit of logic gates is that they naturally detect a large variety of chemicals, 
thus logic gates could be generated with a number of different chemical inputs. Here I 
demonstrate progress towards the production of an OR gate (Table 1). In the future, GPCR-based 
sensors could be used to construct the universal NOR gate (Table 1), which can be used to 
generate any computational operation by layering just a single type of logic gate. 
Table 1: OR and NOR truth table. Given the presence of an input (1) or its absence (0), specific patterns 
of outputs emerge based upon the type of gate present. For an OR gate, the presence of either input A or 
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Figure 1: OR Gate Simple Schematic. Two different G-protein coupled receptors bind their ligands and 
induce the expression of a fluorescent protein independently of one another. 
1.5 G-Protein Coupled Receptor-based yeast sensors 
The yeast Saccharomyces cerevisiae is an attractive target for the expression of 
heterologous GPCRs40, and has been previously used to de-orphanize GPCRs37, 41-43. The 
expression of heterologous GPCRs in yeast has had some success, but is still a difficult task44, 45. 
Recently, the Peralta-Yahya laboratory has engineered the yeast mating pathway to transmit a 
chemical binding event from a heterologous GCPR on the yeast cell surface to a transcription 
factor resulting in the expression of green fluorescent protein46. The yeast mating pathway uses 
a mitogen-activated protein kinase (MAPK) pathway in order to relay signal through the 
recruitment of various protein kinases to a structural scaffold47. The yeast MAPK signaling 
pathway has been extensively studied and has been the subject of several engineering projects 
in an attempt to improve and better understand the signal48, 49. The MAPK pathway in S. cerevisiae 
detects the yeast mating pheromone using the STE2 or STE3 GPCR, which transmits signal to 
STE20 via the Gβ/Gγ complex, STE4 and STE18, respectively. STE20 activates proteins anchored 
to the STE5 scaffold: STE11, STE7, and finally FUS3. FUS3 goes on to activate the transcription 
factor STE12, which targets several pheromone response promoters, particularly PFUS1 and PFIG1 
(Fig. 2A)47. The Peralta-Yahya laboratory has deleted genes in the MAPK pathway to enable the 
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use of GPCRs as sensors46, including far1, which leads to cell cycle arrest following MAPK 
activation, sst2, which spontaneously inactivates the GPCR signal by aiding in GTP hydrolysis in 
the Gα subunit, and ste2, the native GPCR that would compete with the heterologous GPCR for 
cell surface expression50, 51.  
MAPK pathways are relatively uncommon compared to cyclic AMP (cAMP) and inositol 
trisphosphate/diacylglycerol (IP3/DAG) cascades52. Components of the mammalian cAMP 
cascade have been heterologously expressed in yeast21, 53, 54. The cAMP cascade is found in 
olfactory neurons, using cyclic adenosine monophosphate as a secondary messenger in the 
cascade39. The cascade presented here uses an olfactory GPCR and the Golf type Gα subunit to 
activate the membrane-imbedded protein adenylate cyclase type III, which converts ATP into 
cyclic AMP. cAMP in turn binds to ion channels to stimulate Ca2+ influx required for signal 
propagation along neurons, and protein kinase A to regulate cellular activity, often through cAMP 
response elements (CRE) and cAMP response element binding protein (CREBP) (Fig. 2B)55, 56. 
The core components of this cascade have been expressed in yeast previously to stimulate the 




         
Figure 2: Native Mitogen-Activated Protein Kinase Pathway and Cyclic Adenosine Monophosphate 
Cascade. (A) The yeast mitogen-activated protein kinase (MAPK) cascade found in MATa type yeast. The 
yeast mating hormone secreted by MATα type yeast, α-factor, binds STE2 and leads to the activation of 
the MAPK pathway resulting cell cycle arrest and the activation of mating pathway genes (B) The 
mammalian cyclic AMP (cAMP) cascade. Detection of a ligand by the olfactory receptor leads to an 
accumulation of cAMP inside the cell, which stimulates an influx of Ca2+ and activates Protein Kinase A 
(PKA). 
1.6 Ligands of Interest 
 Decanoic acid and eugenol were selected as the ligands of interest. Decanoic acid is a 
biofuel precursor57 which can be converted to fatty acid methyl esters (FAME), an advanced 
biodiesel58. Decanoic acid and other medium-chain fatty acids produce FAMEs with better cold 
properties than diesel fuel59, 60, and are challenging to produce in microorganisms61-63. Use of a 
decanoic acid biosensor could be extremely useful to advance the engineering of medium chain 
fatty acid production strains, and has already been generated46. Eugenol is a phenylpolypropene 
that is abundant in clove oil and has been used in dentistry due to its anesthetic, antibacterial, 
and anti-inflammatory properties64. Eugenol and other phenylpropenes have also been explored 
as possible therapeutic agents due to their potent antifungal properties65, 66, and has thus been 




1.7 The Receptors GPR40 & MOR-EG 
The human pancreatic GPCR, GPR40, detects medium-chain fatty acids in the 
bloodstream and is of interest in the study of diabetes68. GPR40 was used to signal through the 
yeast mating pathway upon addition of decanoic acid46 following the deletion of ste2, sst2, far1   
(Fig. 3A). The mouse GPCR mOR-EG has a high sensitivity for vanillin and eugenol, and is found 
in the olfactory bulb of mice39. The ligand-binding domain of MOR-EG was inserted between the 
first and seventh helix of the rat I7 GPCR, which has  coupled to the heterologously expressed 
cAMP signaling cascade21 and expressed in yeast to induce signal via eugenol (Fig. 3B).  
       
Figure 3: Schematic of the pathways developed in this study. (A) The mitogen activated protein kinase 
signaling pathway. The native STE2 G-protein coupled receptor was deleted and replaced with GPR40. In 
addition, sst2 and far1 were also deleted to enhance flux through the pathway. PFIG1 controls the expression 
of green fluorescent protein. (B) The cAMP signaling cascade. Gα, Gβ, Gγ, Adenylate cyclase III, cAMP 
response element binding protein, and chimeric I7/MOR-EG G-protein coupled receptor were transformed 
in yeast, using the yeast’s protein kinase A to activate cAMP response element binding protein and produce 




CHAPTER 2: MATERIALS & METHODS 
2.1 Yeast Strain Construction 
 The yeast haploid strain W303 (MATa, leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-
11,15) ∆sst2, ∆far1, ∆ste2::GSHU:: (PPY110) was used in this study46. Various other strains were 
generated from this strain using Delitto perfetto integration technique69, 70. The GSHU core 
cassette contains the I-SceI gene under control of the inducible PGAL1 promoter, as well as the 
hygromycin resistance marker and a counter selectable K. lactis URA3 marker gene. PFIG1-eGFP-
TCYC1 was amplified from pRS415-Leu2-PFIG1-eGFP (PPY586) using primers VP139/VP140 and 
integrated at ste2 after induction of the I-SceI gene and transformation via standard lithium 
acetate protocol to generate strain VP1. PCRE-eGFP-TCYC1 was amplified from pESC-Leu2-PCRE-
eGFP-PTEF1-MOREGChimera (PPY429) using primers VP161/VP140 and integrated into PPY110 
at ste2 using a standard lithium acetate protocol to make strain VP8. PGAL4(5x)-eGFP-TCYC1 was 
amplified from pRS415-Leu2-PGAL4(5x)-eGFP (PPY528) using primers VP157/VP140 and 
integrated into strain PPY110 at ste2 using a standard lithium acetate protocol to make strain 
VP7. Sequences were confirmed through amplification via primers VP167/VP168 from the 
genome, which were 100 base pairs upstream and downstream of the gene. The sample was gel 
purified and the size confirmed, and then sequenced with the amplification primers. 
2.2 Plasmid Construction 
To construct plasmid pESC-His3-PTEF1-ACIII-PADH1-Gγ-PHXT7-MOREG (VP4), pESC-His3-
PTEF1-ACIII-PADH1-Gγ (SS38) was amplified using primers VP90/VP91, PHXT7 was amplified from 
pESC-Ura3-PHXT7-Golf-PTEF1-Gβ (SS41) using primers VP134/VP135, MOREG was amplified from 
pESC-Leu2-PCRE-eGFP-PTEF1-MOREG (SS39) using VP67/VP68, and THXT7 was amplified from 
pESC-Leu2-PTEF1-PHXT7 (SS75) using primers VP86/VP87. The fragments were combined and re-
amplified with primers VP68/VP86, then cloned into the amplified SS38 fragment using Gibson 
assembly, maintaining the ACIII and Gγ genes present in SS38.  
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pESC-Ura3-PHXT7-Golf-PTEF1-Gβ-PADH1-GPR40 (VP3) was constructed in three parts; PADH1 
was cloned from pESC-Trp1-PADH1-CREBP (SS39) using primers VP136/VP137, GPR40 was 
amplified from pESC-His3-PTEF1-GPR40 (PPY469) using primers VP78/126, and THXT7 was 
amplified from SS75 using VP80/VP81. The fragments were combined and re-amplified with 
primers VP126/VP80 and cloned into SS41 using Gibson assembly at PacI/SacI, maintaining the 
Golf and Gβ genes present in the original SS41. 
Synthetic Transcription Factor 3 (STF3) was amplified from pCRG-141 ∆11/8671, 
synthesized by Operon, using primers SS195/AME229 and cloned at PacI/NcoI in SS39 to 
generate pESC-Trp1-PADH1-STF3 (PPY716). 
2.3 Yeast Transformation 
For the decanoic acid sensor strain, pKM469 or pKM685 was transformed into strain VP1 
and VP7, respectively, via standard lithium acetate protocol.  
The eugenol sensor strain was constructed by transforming VP4, SS41, and SS39 or 
pESC-Trp1-PADH1-STF3 into strains VP8 and VP7 via standard lithium acetate protocol. 
2.4 Flow Cytometry Procedure 
Decanoic Acid Detection: The cells were grown overnight in synthetic complete media 
with 2% glucose and lacking histidine (SD glu (H-)). The next day, the cells were used to inoculate 
20 mL of SD glu (H-) in a 250 mL flask to an OD600= 0.06 and incubated for 18 hrs at 15 oC (150 
r.p.m.). The cells were centrifuged at 1800g for 2 minutes, re-suspended in 1 mL of water, and 50 
μL of cells were used to inoculate 5 mL of SD glu (H-) in a 5 mL tube containing 50 μL of decanoic 
acid or eugenol dissolved in DMSO (0-800 μM) and the final concentration of DMSO was no 
greater than 1% vol/vol, well below the IC50 of 10% v/v72. The 800 μM maximum was still below 
the reported solubility of decanoic acid in water73, so precipitation was not a concern. The cells 




Eugenol Detection: The cells were grown overnight in synthetic complete media with 2% 
glucose and lacking histidine, uracil, and tryptophan (SD glu (H-U-W-)). The next day, the cells 
were used to inoculate 20 mL of SD glu (H-U-W-) in a 250 mL flask to an OD600= 0.06 and 
incubated for 18 hrs at 15 oC (150 r.p.m.). The cells were centrifuged at 1800 g for 2 minutes, re-
suspended in 1 mL of water, and 50 μL of cells were used to inoculate 5 mL of SD glu (H-U-W-) in 
a 5 mL tube containing 50 μL of decanoic acid or eugenol dissolved in DMSO (0-800 μM) and the 
final concentration of DMSO was no greater than 1% vol/vol. The cells were incubated at 30 oC 
for 4 hours (250 r.p.m) before reading cell fluorescence using a flow cytometer. 
GFP fluorescence was measured using a BD LSRII flow cytometer with the following 
settings: 488 nM laser line, 515−545 nm filter, FSC: 178 V, SSC: 122 V, FITC: 600 V. 
Fluorescence data was collected from 10,000 viable cells for each experiment.  
2.5 Data Analysis 
Flow cytometry histogram analysis was done using FlowJo software. Samples were 
exported from the BD LSRII in fcs3.0 format, and imported into FlowJo. The population was gated 
on a forward vs side scatter plot to remove significant size outliers, and the median green 
fluorescence of the sub-population was measured. This was repeated in triplicate for each 
sample. The measured fluorescence had the fluorescence of a control strain subtracted from 
them, using strains VP1 or VP7 transformed via standard lithium acetate protocol with plasmid 
pESC-His3 for the decanoic acid strains, and VP8 or VP7 containing plasmids pESC-His3, pESC-
Ura3, and pESC-Trp1 for the eugenol and combined strains. Resulting values were averaged and 




CHAPTER 3: RESULTS & DISCUSSION 
3.1 Strains Required 
For this project, several yeast strains needed to be constructed21, 46. First, the reporter 
gene PFIG1-eGFP needed to be integrated into the yeast strain lacking  ste2, far1, and sst2 
(PPY110)46, given that the GPR40-based sensor carrying the reporter gene in a centromeric 
plasmid had a significant amount of noise46. The reporter gene of the cAMP cascade, PCRE-eGFP, 
was also integrated. The olfactory cAMP cascade reconstituted in yeast21 was modified to use the 
constitutive promoters PTEF1 rather than galactose-inducible promoters. Integration of the 
reporters will not only reduce noise, but also plasmid burden. The reporter gene PGAL4(5x)-eGFP 
was also integrated into strain PPY110 and used with synthetic transcription factors in an attempt 
to obtain a greater fold signal from receptors GPR40 and MOR-EG. The native transcription factor 
STE12 was not deleted and is still active in strains VP1, VP7, and VP8. 
3.2 Overview of Signaling Cascades 
To determine that the MAPK and cAMP signaling cascades could be used to make 
orthogonal GPCR-based biosensors, each pathway had to be constructed and tested individually. 
Prior precedent existed for the MAPK pathway using GPR4046, which was altered to use an 
integrated PFIG-eGFP.  
Previously, the rat Golf, Gβ2, Gγ5, and Adenylate Cyclase III (ACIII) along with a human 
cyclic AMP response element binding protein (CREBP) and chimeric rat I7 GPCR had been 
transformed in yeast under galactose inducible promoters21. These proteins were instead cloned 
here under the TEF1, HXT7, and ADH1 constitutive promoters, and the GPCR was modified to 
include the same 1st and 7th helices of the rat I7 GPCR, but the 2nd through 6th helix of the receptor 
MOR-EG, which has a high affinity for eugenol and vanillin39. In this manner, addition of eugenol 
should lead to production of cAMP via ACIII and use the yeast protein kinase A (PKA) to activate 




3.3 Testing MAP Kinase Pathway and the GPR40 GPCR with Decanoic Acid 
Initial testing of the MAPK pathway using GPR40 as the GPCR and decanoic acid 
generated a dose-dependent response. As can be seen in Figure 4A, addition of even 50 μM of 
decanoic acid leads cells containing GPR40 leads an increase in fluorescence, with a linear range 
of ~50-400 μM decanoic acid (R2 = 0.937) and a ~2-fold dynamic range across the linear range. 
3.4 Testing cAMP Cascade and the MOR-EG GPCR with Eugenol 
Incubation of the cAMP cascade with eugenol and the MOR-EG GPCR also produced a 
dose-dependent response (Fig. 4B). To maintain consistency, eugenol was also dissolved in 
DMSO despite being already in a liquid phase and having a higher solubility in water than 
decanoic acid74. For the concentration range tested, green fluorescence did not appear to reach 
a maximum, providing a linear range of ~50-800 μM (R2 = 0.995) and a ~2.5-fold dynamic range 
across the linear range. Vanillin was also tested, but generated no significant signal (data not 
shown). 
  
Figure 4: Dose dependent response of the MAPK pathway-dependent GPR40 sensor with decanoic 
acid and cAMP cascade-dependent MOR-EG sensor with eugenol.  (A) Use of integrated PFIG-GFP 
and GPR40 with the MAPK pathway. (B) Use of integrated PCRE-GFP and MORE-EG with the cAMP 
cascade. Autofluorescence was measured with strain VP1 bearing blank plasmid pESC-His3 (for A) and 
strain VP8 bearing blank plasmids pESC-His3, pESC-Ura3, and pESC-Trp1 (for B) and subtracted from 
the sensor response. Each point was measured in triplicate and the error bars represent the standard 




3.5 Use of Synthetic Transcription Factors 
To improve performance of the sensors, five Gal4 binding sites were placed in a minimal 
promoter to make a synthetic Gal4(5x) promoter46. The yeast Gal4 DNA binding protein is a potent 
regulator that has been well studied as a model regulatory mechanism75 and has a high binding 
affinity for its target sequence76. However, the STE12 and CREBP transcription factors used 
previously are incapable of binding to PGal4(5x), so a different transcription factor must be used. For 
the MAPK pathway, the synthetic transcription factor STF1, bearing the Gal4 DNA binding 
domain, a B42 activation domain, and the STE12 phosphorylation domain was used in a manner 
identical to previous work46, creating the network shown in Fig. 5A. The method presented here 
is different, however, in that the transcription factor STE12 was not deleted. This creates a system 
where the native transcription factor and synthetic transcription factor are phosphorylated. Despite 
this fact, increasing amounts of decanoic acid led to a dose-dependent response similar to what 
was seen using STE12 and PFIG1 (Fig. 5B), with a linear range of ~50-400 μM decanoic acid (R2 
= 0.993) and a ~4.5-fold dynamic range across the linear range. This result is unsurprising given 
the high affinity of the Gal4 DNA binding domain for its sequence, and demonstrates that the 




Figure 5: MAPK pathway with the GPR40 GPCR and using integrated PGAL4(5x) (A) Use of PGAL4(5x) 
requires a synthetic transcription factor, synthetic transcription factor 1 (STF1), to interface between the 
MAPK pathway and GFP. (B) Decanoic Acid stimulates green fluorescence in a dose-dependent manner 
when using STF1 and integrated PGAL4(5x). Autofluorescence was measured with strain VP7 bearing blank 
plasmid pESC-His3 and was subtracted from the sensor response. Each point was measured in triplicate 
and the error bars represent the standard deviation from the mean. 
The cAMP cascade was also modified to use PGAL4(5x) and a synthetic transcription factor. 
To have signal upon eugenol activation, the yeast Gal4 DNA binding domain was fused to a 
minimal CRE phosphorylation and activation domain71, creating the signal transduction pathway 
in Fig. 6A. PCRE and CREBP have been reported to have a KD of 2 ± 1 nM77, while the GAL4 DNA 
binding domain and the GAL4 binding sequence have a reported KD of 13 ± 4 nM76. Adding 
eugenol led to a dose-dependent response, with a linear range of ~50-800 μM (R2 = 0.835) and 






Figure 6: cAMP cascade with the MOR-EG GPCR and using integrated PGAL4(5x) (A) Use of PGAL4(5x) 
requires a synthetic transcription factor, synthetic transcription factor 3 (STF3), to interface between the 
cAMP cascade and GFP. (B) Eugenol stimulates green fluorescence in a dose-dependent manner when 
using STF3 and integrated PGAL4(5x). Autofluorescence was measured with strain VP7 bearing blank 
plasmids pESC-His3, pESC-Ura3, and pESC-Trp1 and subtracted from the sensor response. Each point 
was measured in triplicate and the error bars represent the standard deviation from the mean. 
3.6 Examination of Cross-Talk 
Before the OR gate was examined, the pathways were tested using alternate ligands to 
confirm that the cAMP cascade was incapable of being activated by decanoic acid, and that the 
MAPK pathway was incapable of being activated by eugenol. The results demonstrate that 
eugenol has an insignificant influence upon the MAPK pathway with either the integrated PFIG1 
promoter (Fig 7A) or the integrated PGAL4(5x) promoter (Fig 7B). It should be noted that STE12 is 
still active in the PGAL4(5x) strain.  
When decanoic acid was incubated with the cAMP cascade, however, a significant change 
in florescence from background could be seen, but decanoic acid appeared to cause a decrease, 
rather than an increase in fluorescence for both the integrated PCRE promoter (Fig 8A) and 
integrated PGal4(5x) promoter (Fig 8B). This leads to the conclusion that decanoic acid is incapable 





Figure 7: MAPK pathways with the GPR40 GPCR and decanoic acid or eugenol. (A) The MAPK 
pathway using integrated PFIG1 demonstrates a minor increase in fluorescence when exposed to eugenol, 
compared to a massive increase from decanoic acid. The decanoic acid curve is the same as in Figure 4A 
(B) MAPK using integrated PGAL4(5x) demonstrates an insignificant increase in fluorescence when exposed 
to eugenol, compared to a massive increase from decanoic acid. The decanoic acid curve is the same as 
in Figure 5B. Autofluorescence was measured with strain VP1 (for A) or VP7 (for B) bearing blank plasmid 
pESC-His3, and subtracted from the sensor response. Each point was measured in triplicate and the error 
bars represent the standard deviation from the mean. 
 
Figure 8: cAMP cascades with the MOR-EG GPCR and decanoic acid or eugenol. (A) cAMP using 
integrated PCRE demonstrates an significant increase in fluorescence when exposed to eugenol, compared 
to a significant decrease from decanoic acid. The eugenol curve is the same as seen in Figure 4B. (B) 
cAMP using integrated PGAL4(5x) demonstrates a significant increase in fluorescence when exposed to 
eugenol, compared to a significant decrease from decanoic acid. The decanoic acid curve is the same as 
seen in Figure 6B. Autofluorescence was measured from strain VP8 (for A) or VP7 (for B) bearing blank 
plasmids pESC-His3, pESC-Ura3, and pESC-Trp1 and subtracted from the sensor response. Each point 





CHAPTER 4: CONCLUSION & FUTURE SCOPE 
4.1 Completion of OR Gate 
Preliminary data has been presented here to make a GPCR-based OR gate in yeast. A 
previous method by which the MAPK signaling pathway in S. cerevisiae was used as a 
biosensor46 was modified by integrating the reporter gene. A cAMP-dependent GPCR-based 
sensor21 was also modified that does not rely upon galactose for induction. Both signaling 
cascades were modified to use a synthetic transcription factor in an attempt to achieve a greater 
dynamic range, and demonstrated a greater increase in fluorescence from the MAPK pathway, 
but a smaller dynamic range from the cAMP cascade. In the future, the MAPK pathway and the 
cAMP cascade should be able to be combined to create an OR gate. Thus, using a modified 
MAPK pathway with a minimal Gal4 promoter and a deleted ste12, combined with the cAMP 
pathway using the CRE promoter, a robust OR gate using parallel, orthogonal pathways should 
be able to be created. This would allow for more customization of signal than simply co-expressing 
two GPCRs using the same pathway 
In order to construct a GPCR-based logic gate, the two signaling cascades would need to 
be combined into a single cell in a manner that minimized cross-talk between the two pathways. 
While an OR gate must simply demonstrate that decanoic acid and eugenol can both produce a 
fluorescent signal from a single cell, meaning that cross-talk becomes irrelevant, other logic gates 
are more particular. To accomplish this goal, the GAL4(5x) strain, VP7, should have PCRE-
mKATE2 integrated (Fig. 9). In addition, STE12 needs to be deleted to direct the MAPK pathway 
towards PGAL4(5x). In this manner, a two color system may be used to monitor the signal coming 
through both cascades. As has been demonstrated, the GAL4(5x) promoter is more effective at 
activating GFP expression via the MAPK pathway than the FIG promoter, even with STE12 
competing for transcription factor activation. The CRE promoter is more effective at activating 
GFP expression for the cAMP cascade than the GAL4(5x) promoter. I hypothesize that deleting 
ste12 would enhance activity of the MAPK pathway to produce GFP. Therefore, GPR40 and STF1 
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need only to be combined with the cAMP cascade controlling GFP expression under the CRE 
promoter. mKATE2 has been shown to be a highly effective red fluorescent protein in S. 
cerevisiae78 and would thus make an ideal reporter for the cAMP cascade. 
  
Figure 9: Proposed OR gate schematic using the GPR40 GPCR and integrated PGAL4(5x), and the 
MOR-EG GPCR and integrated PCRE. Introduction of either eugenol or decanoic acid would lead to the 
generation of a fluorescent signal, green for decanoic acid, and red for eugenol. The absence of a red 
signal in the presence of decanoic acid would demonstrate that the MAPK pathway is minimally interacting 
with the cAMP cascade, as would the absence of a green signal in the presence of eugenol. 
To generate the proposed OR gate, I propose that the following steps need to be taken: 
(1) create and test the OR gate, and (2) improve the signal transduction through the use of 
stronger promoters to drive the expression of proteins in the cAMP cascade. The cAMP cascade 
uses a combination of TEF1, ADH1, and HXT7 promoters. While PTEF1 and PADH1 are known to 
be strong, PHXT7 has been shown to be much weaker79. Given that both MOR-EG chimera and 
Gα subunit expression are controlled by PHXT7, flux through the cascade may be limited at this 
point by low quantities of MOR-EG and Gα protein necessary to propagate signal, thus leading to 
a lower overall fluorescence. Use of stronger promoters would provide a means to test this 
hypothesis. MOR-EG and Gα are the entry points of signal into the cascade, binding eugenol and 
transmitting signal to ACIII, respectively, and reduced protein levels may be limiting the maximum 
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amount of signal that can be transmitted through the cascade. The PGK1 and TDH3 promoters 
have both been shown to have similar strengths to ADH1 and TEF179. Use of a more powerful 
constitutive promoter such as PPGK1 or PTDH3 instead of PHXT7 could therefore improve the 
effectiveness of cAMP signaling.  
4.2 Generation of Other Logic Gates 
Moving beyond this project, generation of a universal NOR or NAND logic gate would be 
of particular importance. NOR and NAND gates are important in computation because the can be 
layered to make any other logic gate that exists, as compared to OR gates, which can only make 
more OR gates. A NOR gate would complement the OR gate that would be developed here. 
Although several synthetic NOR gates have been generated using transcription factors80-82, and 
a few with RNA based sensors19, 83, only a single NOR gate has been generated using a GPCR84. 
The previous GPCR-based NOR gate was established across different cells to communicate with 
one another. Several strategies have been considered through the development of this project, 
primarily involving making repressors instead of activators. The first idea tried was moving the 
TATA box, required for RNA polymerase binding, upstream of the transcription factor’s binding 
domain85, but this was found to be ineffective. As an alternative, the yeast Cyc8-Tup1 complex 
was examined as a possible means to create a repressor. Cyc8, also referred to as Ssn6, binds 
to 4 units of Tup1 to both block the activation domain of recruiting proteins and by histone 
deacytylation86. Use of a truncated Cyc8 protein (residues 1-351) fused to the LexA DNA binding 
domain has demonstrated increased fold repression over a simple LexA-Cyc8 fusion87, and could 
be adapted to make a repressor. A functional repressor would allow for the construction of the 
universal NOR and NAND gates that are important in computation. 
4.3 Potential Application: Flocculation 
An application for the OR gate involves making a biosensor capable of rapid removal from 
media when desired, and provides flexibility by allowing two different chemicals to act as 
activators. Yeast have been proposed for use as a sensor strain for bioproduction, and have seen 
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extensive use as a screening tool88. A cheap and simple reporter would be yeast flocculation. 
Flocculation is the process by which yeast sediment together, and is critical in the brewing 
industry, where flocculated yeast are removed from fermentation batches in order for use in 
subsequent fermentations89-91. Flocculation is caused by cell-surface flocculation proteins binding 
to mannose chains found on the cell walls of other yeast, which causes aggregation of cells into 
multicellular flocs92. The W303 strain of S. cerevisiae is incapable of flocculation due to an inactive 
flo8 gene93, which is essential for activation of several proteins essential for flocculation, including 
FLO1 and FLO1194. However, overexpression of gts1, a gene responsible for budding and cell 
size95, is capable of inducing flocculation in W303 yeast96. As such, controlling the expression of 
gts1 under PCRE or PFIG1 would allow the yeast to flocculate in the presence of a ligand. An OR 
gate capable of flocculation would allow for simultaneous sensing of two ligands at the same time 
with a rapid, easily detectable response capable of viewing with the naked eye. Thus, two equally 





Table A.1 Table of Yeast Strains 
Strain # Name Description Reference
PPY110 PPY110 W303 (MATa, leu2-3,112 trp1-1 can1-100 ura3-
1 ade2-1 his3-11,15), ∆sst2, ∆far1, 
∆ste2::GSHU:: 
Mukherjee et. al. 
ACS Synthetic 
Biology, (2015). 
PPY870 VP1 W303, ∆sst2, ∆far1, ∆ste2::PFIG1-eGFP:: This study 
PPY960 VP7 W303, ∆sst2, ∆far1, ∆ste2::PGAL4(5x)-eGFP:: This study 
PPY962 VP8 W303, ∆sst2, ∆far1, ∆ste2::PCRE-eGFP:: This study 
 
Table A.2 Table of Plasmids 
Strain # Name Description Reference 
PPY34 pESC-His3 pESC-His3 Agilent 
PPY35 pESC-Ura3 pESC-Ura3 Agilent 
PPY36 pESC-Trp1 pESC-Trp1 Agilent 
PPY428 
 




PPY441 SS41 pESC-Ura3-PHXT7-Golf-PTEF1-Gβ Stephen Sarria 
PPY466 SS49 pESC-Trp1-PTEF1-PADH1-CREBP Stephen Sarria 
PPY469 pKM469 pESC-His3-PTEF1-GPR40 Mukherjee et. al. 
ACS Synthetic 
Biology, (2015). 
PPY528 PKM528 pESC-Leu2-PGAL4(5x)-eGFP Mukherjee et. al. 
ACS Synthetic 
Biology, (2015). 
PPY586 pKM586 pRS415-Leu2-PFig1-GFP Mukherjee et. al. 
ACS Synthetic 
Biology, (2015). 
PPY685 pKM685 pESC-His3-PTEF1-GPR40-PADH1-STF1 Mukherjee et. al. 
ACS Synthetic 
Biology, (2015). 
PPY697 SS75 pESC-Leu2-PTEF1-PHXT7 Stephen Sarria 
PPY716 pESC-Trp1-
ADH-STF3 
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